Подписаться
Christian Meyer
Christian Meyer
Подтвержден адрес электронной почты в домене colorado.edu
Название
Процитировано
Процитировано
Год
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ...
autophagy 17 (1), 1-382, 2021
105882021
Quantifying drug combination synergy along potency and efficacy axes
CT Meyer, DJ Wooten, BB Paudel, J Bauer, KN Hardeman, D Westover, ...
Cell systems 8 (2), 97-108. e16, 2019
1502019
Charting the fragmented landscape of drug synergy
CT Meyer, DJ Wooten, CF Lopez, V Quaranta
Trends in pharmacological sciences 41 (4), 266-280, 2020
602020
MuSyC is a consensus framework that unifies multi-drug synergy metrics for combinatorial drug discovery
DJ Wooten, CT Meyer, ALR Lubbock, V Quaranta, CF Lopez
Nature communications 12 (1), 4607, 2021
59*2021
Dependence on glycolysis sensitizes BRAF-mutated melanomas for increased response to targeted BRAF inhibition
KN Hardeman, C Peng, BB Paudel, CT Meyer, T Luong, DR Tyson, ...
Scientific reports 7 (1), 42604, 2017
552017
Guidelines for the use and interpretation of assays for monitoring autophagy 1
DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ...
322021
Differential cell susceptibilities to KrasG12D in the setting of obstructive chronic pancreatitis
C Shi, FC Pan, JN Kim, MK Washington, C Padmanabhan, CT Meyer, ...
Cellular and molecular gastroenterology and hepatology 8 (4), 579-594, 2019
202019
Translatome proteomics identifies autophagy as a resistance mechanism to on-target FLT3 inhibitors in acute myeloid leukemia
SE Koschade, K Klann, S Shaid, B Vick, JA Stratmann, M Thölken, ...
Leukemia 36 (10), 2396-2407, 2022
152022
Activation of STAT3 through combined SRC and EGFR signaling drives resistance to a mitotic kinesin inhibitor in glioblastoma
RS Kenchappa, A Dovas, MG Argenziano, CT Meyer, LE Stopfer, ...
Cell reports 39 (12), 2022
92022
Machine learning establishes single-cell calcium dynamics as an early indicator of antibiotic response
CT Meyer, MP Jewell, EJ Miller, JM Kralj
Microorganisms 9 (5), 1000, 2021
72021
A high-throughput and low-waste viability assay for microbes
CT Meyer, GK Lynch, DF Stamo, EJ Miller, A Chatterjee, JM Kralj
Nature Microbiology 8 (12), 2304-2314, 2023
22023
A global sensitivity analysis of a mechanistic model of neoadjuvant chemotherapy for triple negative breast cancer constrained by in vitro and in vivo imaging data
G Lorenzo, AM Jarrett, CT Meyer, JC DiCarlo, J Virostko, V Quaranta, ...
Engineering with Computers, 1-31, 2023
22023
MuSyC dosing of adjuvanted cancer vaccines optimizes antitumor responses
D Taylor, CT Meyer, J Fu, H Feng, V Quaranta, JT Wilson, YJ Kim, ...
Frontiers in immunology 13, 936129, 2022
22022
Identifying mechanisms driving the early response of triple negative breast cancer patients to neoadjuvant chemotherapy using a mechanistic model integrating in vitro and in …
G Lorenzo, AM Jarrett, CT Meyer, V Quaranta, DR Tyson, TE Yankeelov
arXiv preprint arXiv:2212.04270, 2022
12022
Abstract PS13-44: Identifying relevant parameters that characterize the early response to NAT in breast cancer patients using a novel personalized mechanistic model integrating …
G Lorenzo, AM Jarrett, CT Meyer, DR Tyson, V Quaranta, TE Yankeelov
Cancer Research 81 (4_Supplement), PS13-44-PS13-44, 2021
12021
Bacterial efflux pump modulators prevent bacterial growth in macrophages and under broth conditions that mimic the host environment
SC Allgood, CC Su, AL Crooks, CT Meyer, B Zhou, MD Betterton, ...
Mbio 14 (6), e02492-23, 2023
2023
A geometry-based approach to make viable-cell counting easy and cheap
JM Kralj, CT Meyer
NATURE MICROBIOLOGY 8 (12), 2242-2243, 2023
2023
Cell-autonomous diversification in bacteria arises from calcium dynamics self-organizing at a critical point
CT Meyer, JM Kralj
Science Advances 9 (31), eadg3028, 2023
2023
In silico analysis of a novel mathematical model integrating in vitro and in vivo imaging data reveals driving mechanisms of breast cancer response to NAT for personalized …
G Lorenzo, AM Jarrett, CT Meyer, DR Tyson, V Quaranta, TE Yankeelov
CANCER RESEARCH 82 (4), 2022
2022
Methods for evaluating therapeutic benefit of combination therapies
CT Meyer, V Quaranta, LA Harris, BB Paudel, DJ Wooten, L Audoly
US Patent App. 17/180,280, 2021
2021
В данный момент система не может выполнить эту операцию. Повторите попытку позднее.
Статьи 1–20